Skip to main content

Protein-protein interaction analysis: the kinetics your structure cannot show

A structure tells you what the complex looks like. It does not tell you how fast the partners find each other, how long they stay together, or whether your engineered variant still binds at all.
Sensitive detection at 0.1 RU RMS baseline noise
Affinity range from 10 pM to 10 mM
From 30 µL of sample per injection

Where structural biologists use label-free binding data

Label-free interaction analysis measures binding between unmodified molecules in real time. For structural biology, it returns affinity, association and dissociation rates, and specificity in solution.

Domain-level interactions

Find out which part of a multi-domain protein carries the binding.

Compare truncations and mutants against the full-length protein.

competitive assays

Predicted complexes

Test an AlphaFold or docking prediction at the bench.

Measure KD to test the predicted interface.

KD validation

Engineered variants

Confirm a construct still binds the way its parent does.

Compare stabilised, truncated, and mutated variants side by side.

variant ranking

Triage before structure determination

Check that the complex forms before structural work.

Confirm binding and complex stability before committing beam or microscope time.

complex stability

Thermodynamics

Measure the same interaction across temperatures.

Add a temperature series to the binding measurement.

16 to 40 °C

Benefits of the inQuiQ in structural biology

01 / 04

One injection, four channels, sixteen sensors

Four independently addressable flow channels, each carrying four sensors, with the sample flowing through the channels in series.

30 µL minimumsequential flow paths
In-flow immobilisation
Spotter immobilisation

Watch the complex form and come apart

The association phase gives kon, the dissociation phase gives koff, and together they give KD. Affinity runs from 10 pM to 10 mM, with steady-state fitting where dissociation is too fast for kinetics.

0.1 RU RMSkon, koff, KD
association, then dissociation

Measure in label-free conditions

The analytes stay unmodified in solution, so it measures native interactions without label or tag artifacts.

  • No tag on either partner to shift affinity or sit across an interface
  • Solution-phase binding, measured in real time
the same binding event

See which domain carries the binding

Compare full-length protein with truncations and point mutants to identify the construct that retains affinity and localise the interaction.

full length
binds
domain removed
no binding
competitive assaysblocking assays
full length, or domain removed

How a binding run works

Every measurement follows the same steps, whatever the complex. One partner is immobilised on the sensor, the other flows past, and the instrument records the response in real time. An endpoint assay gives you one number. The inQuiQ gives you the full curve.

Immobilisation

One binding partner is attached to the sensor surface first.

Amine coupling or tag capture immobilises the protein. The more stable or readily produced partner is usually immobilised, while the other is injected. Ligand density is optimised to avoid mass-transport limitation.

  • amine coupling
  • capture
  • ligand density

Deactivation

Any activated site left unused is deactivated before the first sample arrives.

Without it the surface keeps reacting with sample passing over, and non-specific binding shows up in the trace as signal that has nothing to do with the pair being measured. The response settles at a stable level, the immobilised amount.

  • deactivation
  • blocking
  • non-specific binding

Association

The second partner flows across the surface and the response climbs.

During association, the injected analyte binds to the immobilised target, and the rising response reflects how quickly the complex forms. The association phase determines the on-rate, kon.

  • solvent matching
  • referencing
  • kon

Dissociation

Buffer replaces the sample and the response falls as the complex comes apart.

The dissociation phase gives the off-rate, koff; 1/koff gives complex lifetime. A concentration series gives kon, koff, and KD across 10 pM to 10 mM. For fast dissociation, plateau responses give steady-state affinity. Single-cycle kinetics runs the series uninterrupted when protein is scarce.

  • complex lifetime
  • koff
  • KD
  • steady state
  • SCK

Regeneration

A regeneration buffer strips the bound partner and returns the sensor to baseline, ready for the next injection.

The immobilised partner stays in place, so every variant meets the same surface. Inject, read, regenerate, repeat, unattended. Each injection is read by every sensor, so one sample can cover multiple constructs, mutants, or controls.

  • regeneration
  • automated cycling
  • saveable sequences
Response (RU) Time

What the inQuiQ does for structural biology

Six capabilities, one modular benchtop instrument, in a label-free workflow.

Many constructs, one small sample

4-plex with in-flow immobilisation and 16-plex with a spotter lets you compare truncations, point mutants, and controls from one sample.

16 sensors (spotter required) 30 µL

Resolve weak and transient contacts

Baseline noise stays low enough that a small binding response is still readable.

0.1 RU RMS

From transient contacts to stable complexes

One affinity range covers weak contacts through tight complexes, with steady-state fitting when kinetics are too fast.

10 pM to 10 mM

Localise the interaction

Competitive and blocking assays identify the construct or domain carrying the binding.

competitive blocking

Add thermodynamic detail

The temperature-controlled flow cell runs a full temperature series.

temp. control from 16 to 40 °C

Modular system for an increased throughput

Simply add an autosampler, and run a long variant or condition series unattended.

2×96 wells 2×384 wells
Start A conversation

Talk to an application scientist

Bring your system. We will tell you honestly whether label-free is the right method for it, and how the assay would be built.

Ready to see the inQuiQ in action?

Questions researchers ask

Cryo-EM, X-ray crystallography, and NMR give structure. Label-free interaction analysis, ITC, mass photometry, and SEC-MALS give function and behaviour in solution. Label-free analysis with the inQuiQ adds affinity (KD) and kinetics (kon, koff), so you can show that a modelled interface produces measurable, specific binding under native conditions.

Express the predicted partners, measure their binding in solution, and compare the result with the prediction. A measured KD and a clean sensorgram support the model. Competitive assays against truncations or point mutants then test whether the predicted interface is the one that actually drives binding.

The inQuiQ runs from 30 µL of sample. Sensors are regenerable, so the same chip carries a series of variants, mutants, and controls rather than one measurement per surface. That matters for structural constructs that are slow to express or purify.

Yes, indirectly and reliably. Run the full-length protein on the inQuiQ and its truncations or domain constructs as separate binding experiments, then use competitive and blocking assays to see which construct carries the affinity. The comparison localises the interaction without needing a new structure for every variant.

Affinity (KD) says how tightly two molecules bind at equilibrium. Kinetics says how they get there: kon for how fast the complex forms, koff for how fast it falls apart. Two complexes can share a KD and behave differently, which is why structural work benefits from both.

Precise, accessible, flexible label-free biosensing, powered by integrated photonics.
Careers